Addressing vaccine hesitancy in Europe

Addressing vaccine hesitancy in Europe

Vaccine hesitancy is widely defined as delayed acceptance of vaccines or refusing to vaccinate despite vaccination services being offered. The EU-funded VAX-TRUST project will explore vaccine hesitancy as a societal phenomenon through the application of mixed-methods.

 

 

Estatuto: 
Participant entity
Financed: 
Yes
Entidades: 
Comissão Europeia
Rede: 
VAX-TRUST consortium is led by Tampere University (FI), and involves 10 partner organizations from 7 European countries (FI, BE, PL, PT, UK, IT, CZ)
Keywords: 

vaccine hesitancy, healthcare professionals, parents

Vaccine hesitancy is widely defined as delayed acceptance of vaccines or refusing to vaccinate despite vaccination services being offered. The EU-funded VAX-TRUST project will explore vaccine hesitancy as a societal phenomenon through the application of mixed-methods.

 

 

Observações: 
VAX-TRUST is funded by the Horizon 2020 programme under GA Nº 965280
Parceria: 
International network

VAX-TRUST

Coordenador Geral 
Pia Vuolanto
Coordenador ICS 
Referência externa 
H2020-SC1-BHC-33-2020 - GA965280
Start Date: 
01/03/2021
End Date: 
29/02/2024
Duração: 
36 meses
Closed